HPVC2019-058: Pharmaceutical Products and IV Fluids

Update: 16 April 2025
HSV has made an update to Pharmaceutical Products and IV Fluids agreement (HPVC2019-058). Please find the updated information as below:


Title: HPVITS2019-058.026 Pharmaceutical Products and IV Fluids Supplementary 026.

Contract Commencement Date: 1 April 2025

Details of the awarded outcome was announced on HSV website on 10 April 2025 under Contracts Update section of the Notifications in the dashboard

Note below product details in Supplementary 026 in alphabetical order:

566.01 ABIRATERONE ACETATE 250 MG TABLET, 120

566.02 ABIRATERONE ACETATE 500 MG TABLET, 60

567.01 CARBOPROST 250 MICROGRAMS / ML INJECTION, AMPOULE/VIAL

570.01 PACLITAXEL (AS NANOPARTICLE ALBUMIN-BOUND) 100 MG INJECTION, VIAL

363.01 PALONOSETRON 250 MICROGRAM/5 ML INJECTION, AMPOULE/VIAL 5 ML

568.01 PRUCALOPRIDE 1 MG TABLET, 28

568.02 PRUCALOPRIDE 2 MG TABLET, 28

569.01 SUXAMETHONIUM 100 MG / 2 ML INJECTION, AMPOULE/VIAL 2ml

469.02 THIAMINE HYDROCHLORIDE 100 MG INJECTION, AMPOULE/VIAL

499.02 VANCOMYCIN 125 MG CAPSULE 20

499.03 VANCOMYCIN 250 MG CAPSULE 20


Important Note:
Please ensure that that you are registered to access the Procurement Portal and you’re your details are up to date. More information can be found on the HSV website, or you can contact:

HSV Helpdesk
Phone: (03) 9947 3900
Email: helpdesk@healthsharevic.org.au